Correlation Between ZyVersa Therapeutics and Immutep

Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ZyVersa Therapeutics and Immutep Ltd ADR, you can compare the effects of market volatilities on ZyVersa Therapeutics and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Immutep.

Diversification Opportunities for ZyVersa Therapeutics and Immutep

-0.42

Correlation Coefficient

ZyVersa Therapeutics  Immutep

Very good diversification

The 3 months correlation between ZyVersa and Immutep is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Immutep go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Immutep

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Immutep. In addition to that, ZyVersa Therapeutics is 2.5 times more volatile than Immutep Ltd ADR. It trades about -0.02 of its total potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.02 per unit of volatility. If you would invest  193.00  in Immutep Ltd ADR on October 23, 2024 and sell it today you would earn a total of  0.00  from holding Immutep Ltd ADR or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ZyVersa Therapeutics  vs.  Immutep Ltd ADR

ZyVersa Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Immutep Ltd ADR

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immutep Ltd ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable primary indicators, Immutep is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with ZyVersa Therapeutics and Immutep

The main advantage of trading using opposite ZyVersa Therapeutics and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.

The idea behind ZyVersa Therapeutics and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.